Michael Bennett Medline - Net Worth and Insider Trading
Michael Bennett Medline Net Worth
The estimated net worth of Michael Bennett Medline is at least $634,624 dollars as of 2024-09-22. Michael Bennett Medline is the Director of Bank of Nova Scotia and owns about 8,652 shares of Bank of Nova Scotia (TSX:BNS) stock worth over $634,624. Details can be seen in Michael Bennett Medline's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Bennett Medline has not made any transactions after 2024-08-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Bennett Medline
Michael Bennett Medline Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Bennett Medline owns 1 companies in total, including Bank of Nova Scotia (TSX:BNS) .
Click here to see the complete history of Michael Bennett Medline’s form 4 insider trades.
Insider Ownership Summary of Michael Bennett Medline
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:BNS | Bank of Nova Scotia | 2024-08-29 | Director |
Michael Bennett Medline Latest Holdings Summary
Michael Bennett Medline currently owns a total of 1 stock. Michael Bennett Medline owns 8,652 shares of Bank of Nova Scotia (TSX:BNS) as of August 29, 2024, with a value of $634,624.
Latest Holdings of Michael Bennett Medline
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:BNS | Bank of Nova Scotia | 2024-08-29 | 8,652 | 73.35 | 634,624 |
Holding Weightings of Michael Bennett Medline
Michael Bennett Medline Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Bennett Medline has made a total of 1 transactions in Bank of Nova Scotia (TSX:BNS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bank of Nova Scotia is the acquisition of 4,529 shares on August 29, 2024, which cost Michael Bennett Medline around $299,684.
Insider Trading History of Michael Bennett Medline
- 1
Michael Bennett Medline Trading Performance
Michael Bennett Medline Ownership Network
Michael Bennett Medline Owned Company Details
What does Bank of Nova Scotia do?
Who are the key executives at Bank of Nova Scotia?
Michael Bennett Medline is the Director of Bank of Nova Scotia. Other key executives at Bank of Nova Scotia include Senior Officer Brian J Porter , Director & Senior Officer Scott Thomson , and Senior Officer Philip Thomas .
Bank of Nova Scotia (TSX:BNS) Insider Trades Summary
Over the past 18 months, Michael Bennett Medline made 1 insider transaction in Bank of Nova Scotia (TSX:BNS) with a net purchase of 4,529. Other recent insider transactions involving Bank of Nova Scotia (TSX:BNS) include a net purchase of 2,200 shares made by Nora Anne Aufreiter ,
In summary, during the past 3 months, insiders sold 0 shares of Bank of Nova Scotia (TSX:BNS) in total and bought 4,529 shares, with a net purchase of 4,529 shares. During the past 18 months, 0 shares of Bank of Nova Scotia (TSX:BNS) were sold and 6,729 shares were bought by its insiders, resulting in a net purchase of 6,729 shares.
Bank of Nova Scotia (TSX:BNS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bank of Nova Scotia Insider Transactions
Michael Bennett Medline Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Bennett Medline. Currently GuruFocus does not have mailing address information for Michael Bennett Medline.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
